SCHEMBL5831469

SCHEMBL5831469

CCCC/C=C(\O)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.47
GRIK1 P39086 1/20 0.46
FAAH O00519 3/20 0.41
SOAT1 P35610 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
F7 P08709 1/20 0.41
F3 P13726 1/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
KMT2A Q03164 1/20 0.41
TSHR P16473 1/20 0.39
CNR1 P21554 1/20 0.38
KDM4E B2RXH2 2/20 0.37
GMNN O75496 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1255448 1.00 EP300 (0.47) EP300GRIK1FAAHSOAT1CYP1A2
SCHEMBL6557190 0.93 EP300 (0.55) EP300FAAHSOAT1CYP1A2CYP2C19
SCHEMBL23674866 0.91 EP300 (0.59) EP300FAAHSOAT1CYP1A2CYP2C19
SCHEMBL367396 0.86
SCHEMBL3221896 0.86
SCHEMBL51444 0.81 EP300 (0.56) EP300GRIK1FAAHCYP1A2CYP2C19
SCHEMBL3015069 0.81 EP300 (0.56) EP300GRIK1FAAHCYP1A2CYP2C19
SCHEMBL29134998 0.79 EP300 (0.43) EP300GRIK1FAAHSOAT1CYP1A2
SCHEMBL7115099 0.79 EP300 (0.48) EP300GRIK1FAAHCYP1A2CYP2C19
SCHEMBL19980211 0.79 EP300 (0.43) EP300GRIK1FAAHSOAT1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7138471-B2 Hydrophilic biomedical compositions COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2006-11-21 US claimed
US-20050004255-A1 Hydrophilic biomedical compositions COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2005-01-06 US claimed
US-6774197-B1 IN SITU ADDITION POLYMERIZATION OF MACROMOLECULAR MONOMERS CONTAINING AMINO- OR HYDROXYL FUNCTIONAL GROUPS; INTRAOCULAR LENSES COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) 2004-08-10 US claimed
US-20250059406-A1 PRESSURE-SENSITIVE ADHESIVE COMPOSITION, PRESSURE-SENSITIVE ADHESIVE SHEET, AND BONDED BODY NITTO DENKO CORPORATION (JP) 2025-02-20 US disclosed
US-20250051616-A1 PRESSURE-SENSITIVE ADHESIVE COMPOSITION, PRESSURE-SENSITIVE ADHESIVE SHEET, AND BONDED BODY NITTO DENKO CORPORATION (JP) 2025-02-13 US disclosed
CN-119366005-A Binder storage container for secondary battery and binder product for secondary battery 日本瑞翁株式会社 2025-01-24 CN disclosed
US-20240409787-A1 PRESSURE-SENSITIVE ADHESIVE COMPOSITION, PRESSURE-SENSITIVE ADHESIVE SHEET, AND BONDED BODY NITTO DENKO CORPORATION (JP) 2024-12-12 US disclosed
US-20240392172-A1 PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND PRESSURE-SENSITIVE ADHESIVE SHEET USING SAID PRESSURE-SENSITIVE ADHESIVE COMPOSITION NITTO DENKO CORPORATION (JP) 2024-11-28 US disclosed
EP-4410919-A1 ADHESIVE COMPOSITION, ADHESIVE SHEET, AND BONDED BODY NITTO DENKO CORPORATION (JP) 2024-08-07 EP disclosed
EP-4410917-A1 ADHESIVE COMPOSITION, ADHESIVE SHEET, AND BONDED BODY NITTO DENKO CORPORATION (JP) 2024-08-07 EP disclosed
EP-4410916-A1 ADHESIVE COMPOSITION, ADHESIVE SHEET, AND JOINED BODY NITTO DENKO CORPORATION (JP) 2024-08-07 EP disclosed
EP-4083150-A1 AQUEOUS INKJET PRINTING INK COMPOSITION Sakata INX Corporation (JP) 2022-11-02 EP disclosed
CN-114981376-A Double-sided adhesive tape 日东电工株式会社 2022-08-30 CN disclosed
CN-114829522-A Double-sided adhesive tape 日东电工株式会社 2022-07-29 CN disclosed
CN-114729237-A Double-sided adhesive tape 日东电工株式会社 2022-07-08 CN disclosed
WO-2021152890-A1 DOUBLE-SIDED ADHESIVE TAPE 日東電工株式会社 2021-08-05 WO disclosed
EP-3780186-A1 BINDER COMPOSITION FOR SECONDARY CELL, SLURRY COMPOSITION FOR SECONDARY CELL FUNCTIONAL LAYER, SECONDARY CELL MEMBER, SECONDARY CELL, AND METHOD FOR MANUFACTURING SLURRY COMPOSITION FOR SECONDARY CELL NEGATIVE ELECTRODE Zeon Corporation (JP) 2021-02-17 EP disclosed
US-20200411870-A1 BINDER COMPOSITION FOR SECONDARY BATTERY, SLURRY COMPOSITION FOR SECONDARY BATTERY FUNCTIONAL LAYER, SECONDARY BATTERY MEMBER, SECONDARY BATTERY, AND METHOD OF PRODUCING SLURRY COMPOSITION FOR SECONDARY BATTERY NEGATIVE ELECTRODE ZEON CORPORATION (JP) 2020-12-31 US disclosed
US-10344249-B2 Gel-like polymer composition obtained by polymerizing a monomer containing acid groups in the presence of a polyether compound BASF SE (DE) 2019-07-09 US disclosed
US-20160369210-A1 GEL-LIKE POLYMER COMPOSITION OBTAINED BY POLYMERISING A MONOMER CONTAINING ACID GROUPS IN THE PRESENCE OF A POLYETHER COMPOUND BASF SE (DE) 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10344249-B2 Gel-like polymer composition obtained by polymerizing a monomer containing acid groups in the presence of a polyether compound ELOVL3, ELOVL1, PTGER1 EP300 2244/4885GRIK1 876/4885FAAH 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.